Yilite Technology has secured over CNY 100 million in two rounds of financing within the year.
Yilite Technology has recently completed a CNY 100 million A+ round of financing. This round was co-led by GT Capital and GTJAIIC, with YiMei Capital as a follow-on investor, and Asia Tech Ventures continuing to serve as the exclusive financial advisor. This follows the company's initial round of financing exceeding CNY 100 million completed in January 2024.
Yilite Technology, a leading domestic company with independent R&D capabilities and mass production of liquid chromatography products, holds a leading market share in domestic HPLC. The company has achieved intellectual property rights for the core components of liquid chromatography through the layout of over a hundred core patents.
With the national emphasis on industrial chain security, based on Yilite's 30 years of experience and accumulation in the field of liquid chromatography, and through the independent research and production of core components as well as cooperation with domestic suppliers, Yilite's own chromatography equipment core components have achieved a domestication rate of 95%. The products can meet the R&D and production needs of customers in various fields such as universities/research, biomedicine, testing, petrochemicals, food, and environmental protection.
Currently, Yilite Technology has built a rich business matrix around the field of liquid chromatography.
Yilite Technology is the only domestic company with experience in mass production of both chromatographic instruments and consumables. The company's series of liquid chromatography products lead the domestic market in terms of market share. To date, the cumulative sales of domestic instruments have exceeded 17,000 units, and the sales of chromatography columns have exceeded 200,000 units.
At the same time, Yilite Technology continues to enrich its product range. The HPLC (High-Performance Liquid Chromatography) covers four models from low to high-end, and it expands vertically into analytical instruments such as UHPLC (Ultra-High-Performance Liquid Chromatography), LC-MS/MS (Triple Quadrupole Liquid Chromatography-Mass Spectrometry), and GC (Gas Chromatography); preparative chromatography covers from semi-preparative/preparative purification systems for laboratory use to industrial-scale preparative systems, as well as precision infusion devices used in synthetic biology and microchemical reactions. In addition to instruments, the company also provides chromatography column consumables and core components such as a series of metering pumps for preparative chromatography.
Furthermore, Yilite Technology is committed to extending into the upstream purification of emerging biotechnologies and the field of clinical analysis and diagnosis, continuously investing in the research and development of a series of instrument products and corresponding chromatography consumable products, to create a three-dimensional business map of "laboratory chemical analysis + upstream purification of emerging biotechnology + clinical analysis and testing". For clinical applications, Yilite Technology has successfully launched products such as clinical-specific hemoglobin A1c and blood drug concentration detection related liquid chromatography instruments.
Currently, Yilite Technology has begun to lay out the overseas sales sector and has reached strategic cooperation agreements with well-known overseas pharmaceutical company customers and has started sales. As of 2023, the company has achieved sales in 45 overseas countries, with users in developed countries such as the United States, Canada, the United Kingdom, and Italy.